Cell replacement therapies to promote remyelination in a viral model of demyelination - Wikidata - awgldk - TriplyDB

Cell replacement therapies to promote remyelination in a viral model of demyelination

Cell replacement therapies to promote remyelination in a viral model of demyelination

http://www.wikidata.org/entity/Q34056814

about

Biomedical and clinical promises of human pluripotent stem cells for neurological disorders Imaging and clinical properties of inflammatory demyelinating pseudotumor in the spinal cord.Two-photon imaging of cellular dynamics in the mouse spinal cord.Neuroprotective effects of oligodendrocyte progenitor cell transplantation in premature rat brain following hypoxic-ischemic injury.Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models.

P2860

Q21284798-5B9C3E07-7DD3-4B77-B8AB-D2D1CB8699BC Q34095447-680B581F-2863-4BCC-AC05-2C78F8B4A45C Q35162319-CBB668AE-8AA5-4638-A792-B1DCE9B27517 Q35196135-DF43A096-0032-4F92-B150-2A6D2F7F047D Q35954507-C9CD87CC-30E4-456A-9244-ECC3E74AEE35 Q38875361-B909E22C-AF98-4267-A26C-FB4B4BF81D83 Q42023621-74C4E848-32F4-4F2E-AAF1-6F71C4FF3E74

P2860

Cell replacement therapies to promote remyelination in a viral model of demyelination

http://www.wikidata.org/entity/Q34056814

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cell replacement therapies to promote remyelination in a viral model of demyelination

@ast

Cell replacement therapies to promote remyelination in a viral model of demyelination

@en

Cell replacement therapies to promote remyelination in a viral model of demyelination

@nl

type

label

Cell replacement therapies to promote remyelination in a viral model of demyelination

@ast

Cell replacement therapies to promote remyelination in a viral model of demyelination

@en

Cell replacement therapies to promote remyelination in a viral model of demyelination

@nl

prefLabel

Cell replacement therapies to promote remyelination in a viral model of demyelination

@ast

Cell replacement therapies to promote remyelination in a viral model of demyelination

@en

Cell replacement therapies to promote remyelination in a viral model of demyelination

@nl

P1433

Q34056814-31E0F180-702E-4F5F-9CD9-B967D19A5569

P1476

Q34056814-2052775C-702D-4236-AD9A-B1E3841486D3

P2093

Q34056814-0EC7B3A7-2F24-4040-BBD5-34D78376F396

Q34056814-4D77CA4A-AFFE-466F-97F2-3935DE1001C8

Q34056814-696F9A08-623A-4426-BDA1-F875B05DC55D

Q34056814-DA09133C-DC10-418C-AC70-D6DA76494936

Q34056814-FBE0918B-A220-4AB0-8901-A4C12A7A962F

P2860

Q34056814-007D0393-3ABD-4C9A-8337-9D96CD0012C1

Q34056814-02AEA358-4923-4378-BA4D-C27E7EA0D3C3

Q34056814-08C2C564-D37B-46F3-8953-B17A5BB01B83

Q34056814-0EDBDA89-EB40-4CE1-8FC3-55BE0DEDB7FB

Q34056814-1119380F-7824-4EED-9A24-97616970ED4D

Q34056814-12A0C819-1F0C-4E91-BF27-863BE927C9D0

Q34056814-15B255AB-BD85-4C39-ADA3-42AF0CE007E5

Q34056814-1C7E24ED-8074-4991-9319-2A97F78FDDE6

Q34056814-1CEA0CE3-B1ED-4807-91AD-78A4D20F62F6

Q34056814-1FA84DA0-71C7-4E1C-8531-70D64CBEBAEA

P304

Q34056814-893D39C3-194E-4BBB-BC28-9486026773D8

P31

Q34056814-9F0D672F-AA2E-437D-B1E1-FB6A7659CDFD

P356

Q34056814-FFE2271F-E227-4250-93D2-352EB331B5B7

P433

Q34056814-7E07C76E-7525-4B96-B8B4-F501D4629A85

P478

Q34056814-14635EC3-2EE5-4C73-B78F-593C7ECBEC90

P577

Q34056814-DC2FA135-1DE2-48EB-BAF1-B700A7C299BD

P5875

Q34056814-ADF80C69-781F-48AE-AA27-ADC81D3849BA

P698

Q34056814-B16D835A-5678-41D1-A001-487F8592514A

P932

Q34056814-547AF732-A59C-4430-AD7F-D51F5E8AD2D1

P356

J.JNEUROIM.2010.05.013

P1433

Journal of Neuroimmunology

P1476

Cell replacement therapies to promote remyelination in a viral model of demyelination

@en

P2093

Chris S Schaumburg

http://www.w3.org/2001/XMLSchema#string

Emanuele Tirotta

http://www.w3.org/2001/XMLSchema#string

Kevin S Carbajal

http://www.w3.org/2001/XMLSchema#string

Lucia Whitman

http://www.w3.org/2001/XMLSchema#string

Thomas E Lane

http://www.w3.org/2001/XMLSchema#string

P2860

Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

Environmental risk factors for multiple sclerosis. Part I: The role of infection

Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway

Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury

Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.

A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination

Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus.

Why does remyelination fail in multiple sclerosis?

MHV infection of the CNS: mechanisms of immune-mediated control.

P304

101-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2010.05.013

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

224

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45184652

http://www.w3.org/2001/XMLSchema#string

P698

20627412

http://www.w3.org/2001/XMLSchema#string

P932

2919340

http://www.w3.org/2001/XMLSchema#string